Activist 13D/13G Filings - ADDEX THERAPEUTICS LTD ADS (ADXN)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-08-14
8:12 pm
Sale
13DADDEX THERAPEUTICS LTD ADS
ADXN
Growth Equity Opportunities Fund IV LLC0
0.000%
-6,624,600decrease
(Position Closed)
View
2024-08-05
9:00 pm
Sale
13DADDEX THERAPEUTICS LTD ADS
ADXN
Growth Equity Opportunities Fund IV LLC6,624,600
5.100%
-1,080,000decrease
(-14.02%)
View
2023-12-08
2:11 pm
Purchase
13DADDEX THERAPEUTICS LTD ADS
ADXN
Growth Equity Opportunities Fund IV LLC7,704,600
6.400%
7,704,600increase
(New Position)
View
2023-11-29
4:00 pm
Purchase
13DADDEX THERAPEUTICS LTD ADS
ADXN
Dyer Timothy Mark16,863,355
14.160%
16,863,355increase
(New Position)
View
2023-04-10
4:06 pm
Unchanged
13DADDEX THERAPEUTICS LTD ADS
ADXN
Growth Equity Opportunities Fund IV LLC7,704,600
8.500%
0
(Unchanged)
View
2023-04-05
4:00 pm
Unchanged
13DADDEX THERAPEUTICS LTD ADS
ADXN
Dyer Timothy Mark9,855,322
11.090%
0
(Unchanged)
View
2023-03-31
4:00 pm
Unchanged
13DADDEX THERAPEUTICS LTD ADS
ADXN
Dyer Timothy Mark9,855,322
12.180%
0
(Unchanged)
View
2023-02-16
2:49 pm
Sale
13GADDEX THERAPEUTICS LTD ADS
ADXN
ARMISTICE CAPITAL LLC675,295
4.990%
-3,363,167decrease
(-83.28%)
View
2023-02-14
12:30 pm
Sale
13GADDEX THERAPEUTICS LTD ADS
ADXN
CAXTON CORP718,849
0.900%
-1,595,640decrease
(-68.94%)
View
2023-02-14
11:53 am
Purchase
13GADDEX THERAPEUTICS LTD ADS
ADXN
ARMISTICE CAPITAL LLC4,038,462
4.970%
3,405,665increase
(+538.19%)
View
2023-02-07
6:08 pm
Sale
13GADDEX THERAPEUTICS LTD ADS
ADXN
GOLDMAN SACHS GROUP INC
GS
2,063
0.000%
-3,004,919decrease
(-99.93%)
View
2023-02-06
4:32 pm
Sale
13GADDEX THERAPEUTICS LTD ADS
ADXN
New Leaf Biopharma Opportunities I L.P.2,316,293
3.000%
-50,000decrease
(-2.11%)
View
2022-11-28
3:19 pm
Unchanged
13DADDEX THERAPEUTICS LTD ADS
ADXN
Growth Equity Opportunities Fund IV LLC7,704,600
9.700%
0
(Unchanged)
View
2022-11-23
06:00 am
Unchanged
13DADDEX THERAPEUTICS LTD ADS
ADXN
Dyer Timothy Mark9,855,322
13.540%
0
(Unchanged)
View
2022-11-09
4:00 pm
Purchase
13DADDEX THERAPEUTICS LTD ADS
ADXN
Dyer Timothy Mark9,855,322
20.010%
5,394,822increase
(+120.95%)
View
2022-08-23
5:18 pm
Unchanged
13DADDEX THERAPEUTICS LTD ADS
ADXN
Growth Equity Opportunities Fund IV LLC7,704,600
15.100%
0
(Unchanged)
View
2022-08-05
06:01 am
Purchase
13DADDEX THERAPEUTICS LTD ADS
ADXN
Dyer Timothy Mark4,460,500
8.400%
829,512increase
(+22.85%)
View
2022-02-18
4:54 pm
Unchanged
13GADDEX THERAPEUTICS LTD ADS
ADXN
New Leaf Biopharma Opportunities I L.P.2,366,293
6.200%
0
(Unchanged)
View
2022-02-14
6:33 pm
Purchase
13GADDEX THERAPEUTICS LTD ADS
ADXN
ARMISTICE CAPITAL LLC632,797
9.990%
632,797increase
(New Position)
View
2022-02-14
4:07 pm
Sale
13GADDEX THERAPEUTICS LTD ADS
ADXN
CAXTON CORP2,314,489
6.000%
-1,804decrease
(-0.08%)
View
Goto 0, 1, Next